A new computational framework illuminates the hidden ecology of diseased tissues
The MESA method uses ecological theory to map cellular diversity and spatial patterns in tissues, offering new insights into disease progression.
The MESA method uses ecological theory to map cellular diversity and spatial patterns in tissues, offering new insights into disease progression.
Since an MIT team introduced expansion microscopy in 2015, the technique has powered the science behind kidney disease, plant seeds, the microbiome, Alzheimer’s, viruses, and more.
The undergraduate lab’s first microscope competition highlights stunning images and student ingenuity.
The framework helps clinicians choose phrases that more accurately reflect the likelihood that certain conditions are present in X-rays.
SPROUT, developed by Lincoln Laboratory and University of Notre Dame researchers, is a vine robot capable of navigating under collapsed structures.
The findings provide new drug targets for stopping the infection’s spread.
New methods light up lipid membranes and let researchers see sets of proteins inside cells with high resolution.
Findings may help predict how rain and irrigation systems launch particles and pathogens from watery surfaces, with implications for industry, agriculture, and public health.
Researchers developed a scalable, low-cost device that can generate high-power terahertz waves on a chip, without bulky silicon lenses.
Tissue processing advance can label proteins at the level of individual cells across large samples just as fast and uniformly as in dissociated single cells.
A small fleet of autonomous surface vessels forms a large sonar array for finding submerged objects.
Using high-powered lasers, this new method could help biologists study the body’s immune responses and develop new medicines.
The method could help communities visualize and prepare for approaching storms.
The Lincoln Laboratory-developed laser communications payload operates at the data rates required to image these never-before-seen thin halos of light.
The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.